Triomics: $22 Million Raised To Scale AI Infrastructure For Oncology Workflows
By Amit Chowdhry ● May 28, 2026
Triomics, an oncology AI company helping cancer centers operationalize complex clinical information, announced it has raised $22 million in Series B financing led by Battery Ventures, with participation from existing investors Nexus Venture Partners, Lightspeed, and Y Combinator, alongside strategic backers Oncology Ventures and Precision Health Informatics, a wholly owned subsidiary of Texas Oncology. The round brings the company’s total funding raised to more than $36 million.